Vaccines Conferences is aimed to give an opportunity that with scholars from around the world focused on learning about Vaccines & Immunology and its advances; this is the best opportunity to reach the largest assemblage of participants from the Vaccines & Immunology community. It provides an explicit platform for presentations, distributes information, meets with current and potential scientists, makes a splash with new vaccines developments, and receive name recognition at this event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Vaccines & Immunology are hallmarks of this conference.

Track 1: Human Vaccines - Infectious & Non Infectious Diseases

A vaccine is an inactivated form of bacteria or virus that is injected into the body to simulate an actual infection. Because the injected microorganisms are 'dead,' they don't cause a person to become sick. Instead, vaccines stimulate an immune response by the body that will fight off that type of illness. It covers infectious disease targets and non-infectious disease targets. To generate vaccine-mediated protection is a complex challenge. Currently available vaccines have largely been developed empirically, with little or no understanding on how they activate the immune system. Their early protective efficacy is primarily conferred by the induction of antigen-specific antibodies. However, there is more to antibody-mediated protection than the peak of vaccine-induced antibody titers.

Related Vaccines Conferences | Immunology Conferences | World Vaccine Congress

5th International Conferences on Infectious Diseases, March 1-2, 2018 Berlin, Germany; 4th World Conferences on Rare Diseases and Orphan Drugs, June 11-12, 2018 Dublin, Ireland; International Conferences on Emerging Infectious Diseases, 31st August-1st September 2018 Zurich, Switzerland; 6^th World Conferences on HIV/AIDS, STDs & STIs, October 29-30 Madrid, Spain; 13^th World Conferences on Infection Prevention and Control, December 14-16, 2017 Rome, Italy; 6^th Euro-Global Conferences on Infectious Diseases, September 7-9, 2017 Paris, France; 3rd International Conferences on Influenza and Zoonotic Diseases, August 21-22, 2017 Birmingham, UK; 18^thInternational Conferences on Infectious Diseases, March 1-4, 2018 Buenos, Argentina; The European Conferences on Clinical Microbiology and Infectious Diseases, April 21-24, 2018 Madrid, Spain; ICID 2018; 20th International Conference on Infectious Diseases, January 29-30, 2018 Sydney, Australia; Twelfth Annual Conferences on Infectious Diseases Update for Primary Care and Hospital Medicine, September 14-15, 2017 Baltimore, USA; 30^th Annual Conferences on Infectious Diseases in Children, November 18-19, 2017 New York, USA; Conferences on Infectious Diseases: Adult Issues in the Outpatient and Inpatient Settings, April 02-06, 2018 Florida, USA; ID Week 2017 Infectious Diseases Conferences, October 4-7, 2017 California, USA; 10^th conferences on Pediatric Infectious Diseases (WSPID), December 2-5, 2017 Shenzhen, China; Online conference: Vaccines: Developments and Optimization, 26-27, 2018.

Related Societies:

Europe:

European Society for Paediatric Infectious Diseases; European Union Geriatric Medicine Society; European Federation of Immunological Societies; European Academy of Allergy and Clinical Immunology

USA:

The Anti-Vaccination Society of America; Infectious Diseases Society of America; Association of Immunization Managers; Clinical Immunology Society

Asia and Middle-East:

Japanese Society for Immunology; Singaporean Society for Immunology; Australasian Society of Clinical Immunology and Allergy

Track 2: Vaccine Research & Development

Vaccine Development is an activity that focuses on a variety of technological initiatives and applied research, which enhance and promote improved systems and practices for vaccine safety. In the past year, the unprecedented Ebola disease outbreak galvanized research and industry response and as we continue to search for solutions, we must review the lessons learned in order to overcome the current challenges. Vaccines development is a long, complex process, often lasting 10-15 years and involving a combination of public and private involvement. The current system for developing, testing, and regulating vaccines developed during the 20th century as the groups involved standardized their procedures and regulations.

Related Vaccines Conferences | Immunology Conferences | World Vaccine Congress

29^th International Conferences on Vaccines and Immunization, March 19-20, 2018 London, UK; 9th Conferences on Molecular Immunology & Immunogenetics, March 08-09, 2018 London, UK; 9^th European Conferences on Immunology, June 14-16, 2018 Rome, Italy; 2^nd International Conferences on Autoimmunity, November 06-07, 2017 Frankfurt, Germany; 11^th International Conferences on Allergy, Asthma & Clinical Immunology, September 07-08, 2017 Edinburgh, Scotland; International Conferences on Emerging Infectious Diseases, 31st August-1st September 2018 Zurich, Switzerland; 6^thWorld Conferences on HIV/AIDS, STDs & STIs, October 29-30 Madrid, Spain; 4^th ESCMID Conferences on Vaccines, September 8-10, 2017 Dubrovnik, Croatia; 2017 International Conferences on Vaccines, October 5-7, 2017 Paris, France; Conferences on Vaccines Research & Development, November 20-22, 2017, Valencia, Spain; 2^nd Global Conferences on Vaccines Research, March 19-20, 2018 London, UK; World Vaccines Conferences Washington 2018, April 3-5, 2018 Washington DC, USA; Global Conferences on Vaccines and Vaccination Techniques, April 16-18, 2018, Dubai, UAE; 4^th  Global Conferences on Virology and Vaccines, April 19-21, 2018 Valencia, Spain; 48^th National Immunization Conferences, May 15-17, 2018 Atlanta, USA; Conferences on Vaccines Technology, June 17-22, 2018 Quebec, Canada; Conferences on HIV Research for prevention October 21-25, 2018 Madrid, Spain; Online conference: Vaccines: Developments and Optimization, 26-27, 2018.

Related Societies:

Europe:

European Academy of Paediatrics; European Malaria Foundation (e-malaria Foundation); European Malaria Vaccine Development (EUROMALVAC); European malaria Vaccine Initiative (EMVI)

USA:

Autism Science Foundation (ASF); Childhood Influenza Immunization Coalition (CIIC); Edward Jenner Vaccine Society; Global Polio Eradication Initiative    

Asia and Middle-East:

Lebanese Society of Allergy and Immunology; Moldavian Society of Allergology & Immunology; Moroccan Society of Allergology and Clinical Immunology

Track 3: HIV Vaccines

An AIDS vaccine does not yet exist, but efforts to develop a vaccine against HIV, the virus that causes AIDS, have been underway for many years. An HIV vaccine could be effective in either of two ways. A “preventive” vaccine would stop HIV infection occurring altogether, whereas a “therapeutic” vaccine would not stop infection, but would prevent or delay illness in people who do become infected, and might also reduce the risk of them transmitting the virus to other people. Although a preventive vaccine would be ideal, therapeutic vaccines would also be highly beneficial. The basic idea behind all HIV vaccines is to encourage the human immune system to fight HIV. 

Related Vaccines Conferences | Immunology Conferences | World Vaccine Congress

6^th World Conferences on HIV/AIDS, STDs & STIs, October 29-30 Madrid, Spain; 29^thInternational Conferences on Vaccines and Immunization, March 19-20, 2018 London, UK ; 9th European Conferences on Immunology, June 14-16, 2018 Rome, Italy; 2^nd International Conferences on Autoimmunity, November 06-07, 2017 Frankfurt, Germany; 11^thInternational Conferences on Allergy, Asthma & Clinical Immunology, September 07-08, 2017 Edinburgh, Scotland; 22^nd International AIDS Conferences (AIDS 2018) July 23-27 2018 Amsterdam, Netherlands; CHA 2018; 20^thInternational Conferences on HIV and AIDS, May 14 - 15, 2018 London, UK; The annual Conferences on Retroviruses and Opportunistic Infections (CROI), March 4 -7, 2018 Massachusetts, USA; 12^th Annual ACTHIV, April 5 - 7, 2018, Chicago, USA; 20^th Bangkok International Conferences on HIV Medicine 2018, January 17 - 19, 2018, Bangkok, Thailand; 2^ndInternational Conferences on HIV, September 01-02, 2017 Barcelona, Spain; 21^stAnnual United States Conferences on AIDS (USCA),  September 07-09, 2017 Washington, DC, USA; 16^th European AIDS Conferences, October 25-28, 2017 Milan, Italy; Australasian  Conferences on AIDS 2017, November 06-08, 2017 Canberra,  Australia; Online conference: Vaccines: Developments and Optimization, 26-27, 2018.

Related Societies:

Europe:

British Society for Immunology; Microbiology Society, London; Society for Applied Microbiology; European Society of Clinical Microbiology and Infectious Diseases

USA:

The Federation of Clinical Immunology Societies; The American Association of Immunologists; American Society for Microbiology; Colombian Allergy, Asthma and Immunology Association; Canadian Society for Immunology

Asia and Middle-East:

Indian society of Allergy, Asthma and Clinical Immunology; Australasian Society of Clinical Immunology and Allergy; Bangladesh Society of Allergy and Immunology

Track 4: Cancer Vaccines

Immunotherapeutics is treatment that uses your body's own immune system to help fight cancer. Get information about the different types of immunotherapy and the types of cancer they are used to treat. The main types of immunotherapy now being used to treat cancer include:

1. Cancer vaccines
2. Monoclonal antibodies
3. Immune checkpoint inhibitors
4. Other, non-specific immunotherapies

Some types of immunotherapy are also sometimes called biologic therapy or biotherapy.

In the last few decades immunotherapy has become an important part of treating some types of cancer. Newer types of immune treatments are now being studied, and they’ll impact how we treat cancer in the future.

Immunotherapy includes treatments that work in different ways. Some boost the body’s immune system in a very general way. Others help train the immune system to attack cancer cells specifically. Immunotherapy works better for some types of cancer than for others. It’s used by itself for some of these cancers, but for others it seems to work better when used with other types of treatment.

Related Vaccines Conferences | Immunology Conferences | World Vaccine Congress

28^th Euro Conferences on Cancer Science & Therapy, August 09-10, 2018 Madrid, Spain; 27^th  International Conferences on Oncology Research & Cancer Stem Cells, May 10-12, 2018 Frankfurt, Germany; 9^th International Conferences on Leukemia and Hematologic Oncology, October 05-06,2017 London, UK; 2^nd International Conferences on Epigenetics & Chromatin, November 06-08, 2017 Frankfurt, Germany; 9^th World Conferences on Biomarkers, December 07-08, 2017 Madrid, Spain; Global Conferences on Oncology & Cancer, March 14-16, 2018 Singapore; A Matter of Life or Death: From Basic Cell Death Mechanisms to Novel Conferences on Cancer Treatments, February 1- 3, 2018, Amsterdam, Netherlands; Radiation Break-through: from DNA damage responses to precision Conferences on cancer therapy, March 12 – 14, 2018 Oxford, UK; Molecular Pathology Approach to Cancer, Amsterdam, Netherlands, 4 - 6 June 2018; 25^th Biennial Conferences on Cancer Research, 30-03 July 2018 Amsterdam, Netherlands; World Conferences on Cancer, October 1-4 2018 Kuala Lumpur, Malaysia; Conferences on Cancer Immunotherapy: Combinations (C5), March 23-27, 2018, Québec, Canada;  Conferences on oncology, September 08-12 2017 Madrid, Spain; Online conference: Vaccines: Developments and Optimization, 26-27, 2018.

Related Societies:

Europe:

Albanian Society of Allergology and Clinical Immunology; Austrian Society of Allergology and Immunology; Belgian Society of Allergy and Clinical Immunology; British Society of Allergy and Clinical Immunology

USA:

Argentine Association of Allergy and Immunology; Argentine Society of Allergy and Immunology; Brazilian Society of Allergy and Immunology; Chilean Society of Allergy and Immunology

 Asia and Middle-East:

Allergy & Immunology Society of Sri Lanka; Allergy and Clinical Immunology Society of Singapore; Allergy and Immunology Society of Thailand

Track 5: Childhood Vaccines

Vaccination given to children is called children Immunization. It is currently recommended that all children receive vaccination against the infectious diseases unless the child has special circumstances, such as a compromised immune system or neurological disorders. In our mobile society, over a million people each day people travel to and from other countries, where many vaccine-preventable diseases remain relatively common. Without vaccines, epidemics of many preventable diseases could return, resulting in increased - and unnecessary - illness, disability, and death among children.

We have record or near record low levels of vaccine-preventable childhood diseases in the United States, but that does not mean these have disappeared. Many of the viruses and bacteria are still circulating in this country or are only a plane ride away. That’s why it’s important that children, especially infants and young children receive recommended immunizations on time.

Related Vaccines Conferences | Immunology Conferences | World Vaccine Congress

20^th International Conferences on Neonatology and Perinatology, December 04-06, 2017 Madrid, Spain; 15^thInternational Conferences on Pediatrics and Conferences on Pediatric Cardiology, February 19-20, 2018 Paris, France; 20^thInternational Conferences on Pediatrics Primary Care, September 03-04, 2018 Zurich, Switzerland; 3^rd International Conferences on Pediatric Surgery, May 07-08, 2018 Frankfurt, Germany; 14^th International Conferences on Clinical Pediatrics, June 14-16, 2018 Rome, Italy; 20^th International Conferences on Viral Hepatitis and Liver Disease, May 14-15, 2018 London, UK; International Conferences on Hepatology 2018 January 15-16, 2018 Paris, France; 11^th Australasian Conferences on Viral Hepatitis, 13-15 August 2018 Adelaide, Australia; AFRAVIH 2018: 9^th edition of the International Francophone Conferences on Hepatitis, April 4 -7 2018 Paris, France; The European Conferences on Clinical Microbiology and Infectious Diseases, April 21-24, 2018 Madrid, Spain; ICID 2018; 20th International Conferences on Infectious Diseases, January 29-30, 2018 Sydney, Australia; Twelfth Annual Conference on Infectious Diseases Update for Primary Care and Hospital Medicine, September 14-15, 2017 Baltimore, USA; World Conferences on Hepatitis 2017, November 1-3 2017, São Paulo, Brazil; 24^th International Conferences on Hepatitis C Virus and Related Viruses (HCV 2017), September 25-28, 2017 Cape Cod, USA; Online conference: Vaccines: Developments and Optimization, 26-27, 2018.

Related Societies:

Europe:

Swiss Society for Microbiology; Federation of European Microbiological Societies; International Society of Vaccines; International Union of Immunological Society

USA:

Ecuadorian Society of Allergy, Asthma, and Immunology; Guatemalan Allergy, Asthma and Clinical Immunology Association; Honduran Society of Allergy and Clincial Immunology

Asia and Middle-East:

Indonesian Society of Allergy and Immunology; Korean Academy of Asthma, Allergy and Clinical Immunology; Malaysian Society of Allergy and Immunology

Track 6: Vaccines safety & Efficacy

Vaccines are the best defense we have against serious, preventable, and sometimes deadly contagious diseases. Vaccines are some of the safest medical products available, but like any other medical product, there may be health risk. Accurate information about the value of vaccines as well as their possible side-effects helps people to make informed decisions about vaccination. The safety of vaccines is carefully monitored, starting early in the product development and continuing for as long as the vaccine is being used. Find out about what is done before and after vaccines are approved for use and what is known about the benefits and safety of specific vaccines. There is a lot of false information about vaccines safety on the Internet. This can be confusing. Discover the answers to common questions and concerns about vaccines.

Related Vaccines Conferences | Immunology Conferences | World Vaccine Congress

6^th Euro-Global Conferences on Infectious Diseases, September 7-9, 2017 Paris, France; 5^th  International Conferences on Infectious Diseases, March 1-2, 2018 Berlin, Germany; 4^th World Conferences on Rare Diseases and Orphan Drugs, June 11-12, 2018 Dublin, Ireland; Vaccines Conferences USA 2018; International Conferences on Emerging Infectious Diseases, 31^st August-1^st September 2018 Zurich, Switzerland; 6^th World Conferences on  HIV/AIDS, STDs & STIs, October 29-30 Madrid, Spain; Vaccines Conferences Asia 2018; 13^th World Conferences on Infection Prevention and Control, December 14-16, 2017 Rome, Italy; Vaccines Conferences Middle east 2018; A Matter of Life or Death: From Basic Cell Death Mechanisms to Novel Cancer Treatments Conferences, February 1- 3, 2018, Amsterdam, Netherlands; Radiation Break-through: from DNA damage responses to precision Conferences on cancer therapy, March 12 – 14, 2018 Oxford, UK; Vaccines Conferences Australia 2018; Molecular Pathology Approach to Cancer, Amsterdam, Netherlands, 4 - 6 June 2018; 25^th Biennial Conferences on Cancer Research, 30-03 July 2018 Amsterdam, Netherlands; World Conferences on Cancer, October 1-4 2018 Kuala Lumpur, Malaysia; Vaccines Conferences Canada 2018;  Conferences on Cancer Immunotherapy: Combinations (C5), March 23-27, 2018, Québec, Canada;  Conferences on oncology, September 08-12 2017 Madrid, Spain; Online conference: Vaccines: Developments and Optimization, 26-27, 2018.

Related Societies:

Europe:

Croatian Society of Allergology and Clinical Immunology; Czech Society of Allergology and Clinical Immunology; Finnish Society of Allergology and Clinical Immunology; French Society of Allergology and Clinical Immunology

USA:

Panamanian Association of Allergology and Clinical Immunology; Paraguayan Society of Allergy, Asthma, and Immunology; Peruvian Society of Allergy and Immunology; Venezuelan Society of Allergy, Asthma and Immunology

Asia and Middle-East:

Philippine Society of Allergy, Asthma and Immunology; Taiwan Academy of Pediatric Allergy Asthma Immunology; Vietnam Association of Allergy, Asthma and Clinical Immunology

Track 7: Vaccination for Pregnant Women

Vaccines can help keep you and your growing family healthy. If you are pregnant or planning a pregnancy, the specific vaccinations you need are determined by factors such as your age, lifestyle, medical conditions you may have, such as asthma or diabetes, type and locations of travel, and previous vaccinations. Benefits of vaccinating pregnant women usually outweigh potential risks when the likelihood of disease exposure is high, when infection would pose a risk to the mother or fetus, and when the vaccine is unlikely to cause harm. All women who will be pregnant (any trimester) during the flu season should be offered this vaccine. Talk to your doctor to see if this applies to you. Tetanus/Diphtheria/Pertussis (Tdap): Tdap is recommended during pregnancy, preferably between 27 and 36 weeks' gestation, to protect baby from whooping cough.

Related Vaccines Conferences | Immunology Conferences | World Vaccine Congress

3^rd International Conferences on Reproductive Health and Medicine, May 21-22, 2018 Vienna, Austria; 4th Annual Conferences and Medicare Expo on Trauma & Critical Care, February 22-23, 2018 Paris, France; Vaccines Conferences USA 2018; 47th Global Nursing & Healthcare Conferences, March 01-03, 2018 London, UK; 7th World Conferences on Breast Cancer, May 10-11, 2018 Frankfurt, Germany; Vaccines Conferences Asia 2018; 13^th World Conferences on Infection Prevention and Control, December 14-16, 2017 Rome, Italy; 27th International Conferences on Oncology Research & Cancer Stem Cells, May 10-12, 2018 Frankfurt, Germany; 28^th Euro Conferences on Cancer Science & Therapy, August 09-10, 2018 Madrid, Spain; 11^th European Conferences on Breast Cancer (EBCC-11), March 21-23, 2018 Barcelona, Spain; Vaccines Conferences Middle east 2018; 35^thAnnual Miami Breast Cancer Conferences, March 8-11, 2018 Florida, USA; A Matter of Life or Death: From Basic Cell Death Mechanisms to Novel Conferences on Cancer Treatments, February 1- 3, 2018, Amsterdam, Netherlands; Radiation Break-through: from DNA damage responses to precision Conferences on cancer therapy, March 12 – 14, 2018 Oxford, UK; Vaccines Conferences Australia 2018; Molecular Pathology Approach to Cancer, Amsterdam, Netherlands, 4 - 6 June 2018; 25^th Biennial Conferences on Cancer Research, 30-03 July 2018 Amsterdam, Netherlands; World Conferences on Cancer, October 1-4 2018 Kuala Lumpur, Malaysia; Conferences on Cancer Immunotherapy: Combinations (C5), March 23-27, 2018, Québec, Canada; Vaccines Conferences Canada 2018; ESMO 2017 Congress-Integrating science into oncology for a better patient outcome, September 08-12 2017 Madrid, Spain; 37^th Annual Conferences on Pregnancy, January 23 - 28, 2017 Las Vegas, USA; Online conference: Vaccines: Developments and Optimization, 26-27, 2018.

Related Societies:

Europe:

Slovenian Association for Allergology & Clinical Immunology; Spanish Society of Allergology and Clinical Immunology; European Federation for Immunogenetics; European Macrophage and Dendritic Cell Society

USA:

American Association of Immunologists; American Association of Pharmaceutical Scientists; American Association of Veterinary Immunologists; American Society for Histocompatibility and Immunogenetics

Asia and Middle-East:

Israel Association of Allergy and Clinical Immunology; Jordanian Society for Allergy and Clinical Immunology; Kuwait Society of Allergy & Clinical Immunology; Japanese Society for Immunology, Japan; Singaporean Society For Immunology, Singapore; Australasian Society of Clinical Immunology and Allergy, Australia

Track 8:  Vaccine Adjuvants & Delivery Technologies

Vaccine adjuvants is an ingredient of a vaccine that helps create a stronger immune response in the patient’s body.  In other words, adjuvants help vaccines work better. Some vaccines made from weakened or dead germs contain naturally occurring adjuvants and help the body produce a strong protective immune response. However, most vaccines developed today include just small components of germs, such as their proteins, rather than the entire virus or bacteria. These vaccines often must be made with adjuvants to ensure the body produces an immune response strong enough to protect the patient from the germ he or she is being vaccinated against. Aluminum gels or aluminum salts are vaccines ingredients that have been used in vaccines since the 1930s.  Small amounts of aluminum are added to help the body build stronger immunity against the germ in the vaccine. Aluminum is one of the most common metals found in nature and is present in air, food, and water. The amount of aluminum present in vaccines is low and is regulated by the U.S. Food and Drug Administration (FDA).

Drug delivery systems are engineered technologies for the targeted delivery and/or controlled release of therapeutic agents. Drugs have long been used to improve health and extend lives. The practice of drug delivery has changed dramatically in the last few decades and even greater changes are anticipated in the near future. Biomedical engineers have not only contributed substantially to our understanding of the physiological barriers to efficient drug delivery—such as transport in the circulatory system and drug movement through cells and tissues—they have contributed to the development of a number of new modes of drug delivery that have entered clinical practice.  Role of vaccine delivery technologies includes rational development of vaccines, achieving immunization goals, supporting best clinical practice.

Related Vaccines Conferences | Immunology Conferences | World Vaccine Congress

10^th International Virology Conferences and Expo, July 02-04, 2018 Vienna, Austria; 8^th Global Conferences on Microbiology & Conferences on Infectious Diseases, February 22-23, 2018 Paris, France; 16^th International Conferences on Pharmaceutical Microbiology and Conferences on Biotechnology, May 21-23, 2018 Vienna, Austria; Vaccines Conferences USA 2018; 4^th World Conferences on Applied Microbiology, November 29-December 01, 2017 Madrid, Spain; 8^th Clinical Microbiology Conferences, October 26-28, 2017 Paris, France; 46^th World Conferences on Microbiology, September 18-19, 2017 Dublin, Ireland; Vaccines Conferences Asia 2018; 13th World Conferences on Healthcare & Technologies, June 14-15, 2018 Dublin, Ireland; A Matter of Life or Death: From Basic Cell Death Mechanisms to Novel Cancer Treatments Conferences, February 1- 3, 2018, Amsterdam, Netherlands; Radiation Break-through: from DNA damage responses to precision Conferences on cancer therapy, March 12 – 14, 2018 Oxford, UK; Vaccines Conferences Middle east 2018; Molecular Pathology Approach to Cancer, Amsterdam, Netherlands, 4 - 6 June 2018; 25^th Biennial Conferences on Cancer Research, 30-03 July 2018 Amsterdam, Netherlands; Vaccines Conferences Canada 2018; World Conferences on Cancer, October 1-4 2018 Kuala Lumpur, Malaysia; Vaccines Conferences Australia 2018; Conferences on Cancer Immunotherapy: Combinations (C5), March 23-27, 2018, Québec, Canada;  Conferences on oncology, September 08-12 2017 Madrid, Spain; Online conference: Vaccines: Developments and Optimization, 26-27, 2018.

Related Societies:

Europe:

European Society for Immunodeficiency; French Society of Immunology; Immunology of Diabetes Society; Deutsche Gesellschaft für Immunologie

USA:

American Academy of Paediatrics (AAP); American College Health Association (ACHA); Association of Immunization Managers (AIM); Association for Professionals in Infection Control and Epidemiology (APIC)

Asia and Middle-East:

Asia Pacific Association of Allergy, Asthma, and Clinical Immunology (APAAACI); Asia Pacific Association of Pediatric Allergy, Respirology and Immunology (APAPARI); Commonwealth of Independent States Society of Allergology and Immunology (CIS Society)

Track 9: Veterinary vaccines

Veterinary vaccines are to improve the health and welfare of companion animals, increase production of livestock in a cost-effective manner, and prevent animal-to-human transmission from both domestic animals and wildlife. Several vaccine types can de distinguished among the second-generation veterinary vaccines, depending whether they are live or inactivated, according to the strain of rabies virus used and the characteristics of the cell substrate chosen for viral replication. More recently a third generation of live veterinary rabies vaccine has been developed using recombinant technology. Depending upon the expression system these vaccines are used either parenterally or orally. Oral rabies vaccines are widely used in foxes in Europe and in racoons in the USA.

Related Vaccines Conferences | Immunology Conferences | World Vaccine Congress

5^th International Conferences on Infectious Diseases, March 1-2, 2018 Berlin, Germany; 4th World Conferences on Rare Diseases and Orphan Drugs, June 11-12, 2018 Dublin, Ireland; Vaccines Conferences USA 2018; International Conferences on Emerging Infectious Diseases, 31st August-1st September 2018 Zurich, Switzerland; Vaccines Conferences Asia 2018; 6th World Conferences on HIV/AIDS, STDs & STIs, October 29-30 Madrid, Spain; 13th World Conferences on Infection Prevention and Control, December 14-16, 2017 Rome, Italy; 6^th Euro-Global Conferences on Infectious Diseases, September 7-9, 2017 Paris, France; 3rd International Conferences on Influenza and Zoonotic Diseases, August 21-22, 2017 Birmingham, UK; Vaccines Conferences Middle east 2018; 90^thAnnual Western Conferences on Veterinary Vaccines, March 4-8, 2018 Las Vegas, USA; 22^nd International AIDS Conferences (AIDS 2018) July 23-27 2018 Amsterdam, Netherlands; CHA 2018; 20^th International Conferences on HIV and AIDS, May 14 - 15, 2018 London, UK; Vaccines Conferences Australia 2018; The annual Conferences on Retroviruses and Opportunistic Infections (CROI), March 4 -7, 2018 Massachusetts, USA; 12^th Annual ACTHIV, April 5 - 7, 2018, Chicago, USA; 20^th Bangkok International Conferences on HIV Medicine 2018, January 17 - 19, 2018, Bangkok, Thailand; 2^ndInternational Conferences on HIV, September 01-02, 2017 Barcelona, Spain; Vaccines Conferences Canada 2018; 21^stAnnual United States Conferences on AIDS (USCA),  September 07-09, 2017 Washington, DC, USA; 16^th European AIDS Conferences, October 25-28, 2017 Milan, Italy; Australasian  Conferences on AIDS 2017, November 06-08, 2017 Canberra,  Australia ; WAAVP 2017 – The 26^th International Conferences on Advancement of Veterinary Parasitology, September 04-08, 2017 Kuala Lumpur, Malaysia; Online conference: Vaccines: Developments and Optimization, 26-27, 2018.

Related Societies:

Europe:

European Academy of Allergy and Clinical Immunology (EAACI); European Molecular Biology Laboratory (EMBL); Medical Research Council (MRC) 

USA:

Hepatitis B Foundation (HBF); Infectious Diseases Society of America (IDSA); National Adult and Influenza Immunization Summit (NAIIS); National Foundation for Infectious Diseases (NFID); Paediatrics Infectious Diseases Society (PIDS)

Asia and Middle-East:

Russian Association of Allergology and Clinical Immunology; Turkish National Society of Allergy and Clinical Immunology; Ukrainian Association of Allergologists and Clinical Immunologists

Track 10:  Geriatric Immunization

Vaccines are an important part of routine preventive care for older adults, but most adults don’t get their vaccines as recommended. Omitting vaccination leaves adults needlessly vulnerable to severe illnesses, long-term suffering and death from preventable infections. Vaccines are recommended for adults of all ages, they are particularly important for older persons who are at great risk of serious debilitating consequences and death from infectious diseases. Vaccination is particularly important for individuals living in nursing homes or assisted living facilities, as disease can spread easily among people in close proximity.

Related Vaccines Conferences | Immunology Conferences | World Vaccine Congress

6^th Euro-Global Conferences on Infectious Diseases, September 7-9, 2017 Paris, France; 5^th  International Conferences on Infectious Diseases, March 1-2, 2018 Berlin, Germany; 4^th World Conferences on Rare Diseases and Orphan Drugs, June 11-12, 2018 Dublin, Ireland; Vaccines Conferences USA 2018; International Conferences on Emerging Infectious Diseases, 31^st August-1^st September 2018 Zurich, Switzerland; 6^th World Conferences on HIV/AIDS, STDs & STIs, October 29-30 Madrid, Spain; Vaccines Conferences Asia 2018; 13^th World Conferences on Infection Prevention and Control, December 14-16, 2017 Rome, Italy; 7^th International Conferences on Geriatrics and Palliative Care, September 4-5, 2017 Edinburgh, Scotland; Vaccines Conferences Middle east 2018; American Conferences on Geriatrics 2018, May 3-5 2018 Orlando, USA; 24^th Nordic Conferences on Gerontology, May 2-4 2018 Oslo, Norway; 2^nd Global Conferences on Vaccines Research, March 19-20, 2018 London, UK; Vaccines Conferences Australia 2018;  World Vaccines Conferences Washington 2018, April 3-5, 2018 Washington DC, USA; Global Conferences on Vaccines and Vaccination Techniques, April 16-18, 2018, Dubai, UAE; 4^th  Global Conferences on Virology and Vaccines, April 19-21, 2018 Valencia, Spain; Vaccines Conferences Canada 2018; 48^th National Immunization Conferences, May 15-17, 2018 Atlanta, USA; Conferences on Vaccines Technology, June 17-22, 2018 Quebec, Canada; Conferences on HIV Research for prevention October 21-25, 2018 Madrid, Spain; Online conference: Vaccines: Developments and Optimization, 26-27, 2018.

Related Societies:

Europe:

British Society for Allergy and Clinical Immunology; British Society for Histocompatibility and Immunogenetics; European Federation of Immunological Societies; European Academy of Allergology and Clinical Immunology

USA:

Voices For Vaccines (VFV); National Institute of Allergy and Infectious Disease (NIAID); American Public Health Association (APHA); American Association for the Advancement of Science (AAAS); American Society for Microbiology (ASM)

Asia and Middle-East:

Australasian Society for Immunology; Australasian Society of Clinical Immunology and Allergy; Israel Association of Allergy and Clinical Immunology; Jordanian Society for Allergy and Clinical Immunology; Japanese Society for Immunology, Japan

Track 11: Vaccines against Viral and Bacterial Diseases

Most vaccines against viral infection are effective at preventing disease. However, they are not 100% effective for a number of reasons, reactions can occur after vaccinations.

It is difficult for many of us today to appreciate the dangers of childhood viral infections.

Most of the vaccines in use against viruses are very effective at preventing disease. However, for a variety of reasons, they can fail:

• The vaccine becomes inactive due to incorrect storage, if used past its expiry date, or if incorrectly administered.
• Individuals unpredictably fail to produce an adequate immune response to the vaccine.
• Vaccine immunity “fades” over time.

 The different vaccine combinations at each time point do not interfere with one another and there is no increased risk of serious side-effects when they are given at the same time.

Bacterial vaccines contain killed or attenuated bacteria that activate the immune system. Antibodies are built against that particular bacteria, and prevents bacterial infection later.

Most vaccines against bacterial infections are effective at preventing disease, reactions can occur after vaccinations. Vaccines are available against tuberculosis, diphtheria, tetanus, pertussis, Haemophilus influenzae type B, cholera, typhoid, and Streptococcus pneumoniae.

Related Vaccines Conferences | Immunology Conferences | World Vaccine Congress

5th International Conferences on Infectious Diseases, March 1-2, 2018 Berlin, Germany; 4th World Conferences on Rare Diseases and Orphan Drugs, June 11-12, 2018 Dublin, Ireland; Vaccines Conferences USA 2018; International Conferences on Emerging Infectious Diseases, 31st August-1st September 2018 Zurich, Switzerland; 6^th World Conferences on HIV/AIDS, STDs & STIs, October 29-30 Madrid, Spain; Vaccines Conferences Asia 2018; 13^th World Conferences on Infection Prevention and Control, December 14-16, 2017 Rome, Italy; 6^th Euro-Global Conferences on Infectious Diseases, September 7-9, 2017 Paris, France; 3rd International Conferences on Influenza and Zoonotic Diseases, August 21-22, 2017 Birmingham, UK; Vaccines Conferences Middle east 2018; 11^th European Conferences on Breast Cancer (EBCC-11), March 21-23, 2018 Barcelona, Spain; 35^thAnnual Miami Breast Cancer Conferences, March 8-11, 2018 Florida, USA; A Matter of Life or Death: From Basic Cell Death Mechanisms to Novel Conferences on Cancer Treatments, February 1- 3, 2018, Amsterdam, Netherlands; Vaccines Conferences Australia 2018; Radiation Break-through: from DNA damage responses to precision Conferences on cancer therapy, March 12 – 14, 2018 Oxford, UK; Molecular Pathology Approach to Cancer, Amsterdam, Netherlands, 4 - 6 June 2018; 25^th Biennial Conferences on Cancer Research, 30-03 July 2018 Amsterdam, Netherlands; World Conferences on Cancer, October 1-4 2018 Kuala Lumpur, Malaysia; Conferences on Cancer Immunotherapy: Combinations (C5), March 23-27, 2018, Québec, Canada; Vaccines Conferences Canada 2018; ESMO 2017 Congress-Integrating science into oncology for a better patient outcome, September 08-12 2017 Madrid, Spain; 37^th Annual Conferences on Pregnancy, January 23 - 28, 2017 Las Vegas, USA; Online conference: Vaccines: Developments and Optimization, 26-27, 2018.

Related Societies:

Europe:

European Society for Paediatric Infectious Diseases; European Union Geriatric Medicine Society; European Federation of Immunological Societies; European Academy of Allergy and Clinical Immunology

USA:

The Anti-Vaccination Society of America; Infectious Diseases Society of America; Association of Immunization Managers; Clinical Immunology Society

Asia and Middle-East:

Japanese Society for Immunology; Singaporean Society for Immunology; Australasian Society of Clinical Immunology and Allergy

Track 12: Human Preventive & Therapeutic Vaccines

A preventative vaccine is administered to a person who is free of the targeted infection. By introducing a part of the virus or an inactive virus (which acts like a decoy) into the body, the immune system reacts by producing antibodies. Preventive vaccines are widely used to prevent diseases like polio, chicken pox, measles, mumps, rubella, influenza (flu), and hepatitis A and B.

In addition to preventive vaccines, there are also “therapeutic vaccines”. These are vaccines that are designed to treat people who already have a disease. Some scientists prefer to refer to therapeutic vaccines as “therapeutic immunogens.

Related Vaccines Conferences | Immunology Conferences | World Vaccine Congress

29^th International Conferences on Vaccines and Immunization, March 19-20, 2018 London, UK; 9th Conferences on Molecular Immunology & Conferences on Immunogenetics, March 08-09, 2018 London, UK; 9^th European Immunology Conferences, June 14-16, 2018 Rome, Italy; Vaccines Conferences USA 2018; 2^nd International Conferences on Autoimmunity, November 06-07, 2017 Frankfurt, Germany; 11^th International Conferences on Allergy, Asthma & Clinical Immunology, September 07-08, 2017 Edinburgh, Scotland; Vaccines Conferences Asia 2018; 5^th International Conferences on Infectious Diseases, March 1-2, 2018 Berlin, Germany; International Conferences on Emerging Infectious Diseases, 31st August-1st September 2018 Zurich, Switzerland; Vaccines Conferences Middle east 2018; 6^thWorld Conferences on HIV/AIDS, STDs & STIs, October 29-30 Madrid, Spain; 90^thAnnual Western Conferences on Veterinary Vaccines, March 4-8, 2018 Las Vegas, USA; 22^nd International AIDS Conferences (AIDS 2018) July 23-27 2018 Amsterdam, Netherlands; CHA 2018; 20^thInternational Conferences on HIV and AIDS, May 14 - 15, 2018 London, UK; The annual Conferences on Retroviruses and Opportunistic Infections (CROI), March 4 -7, 2018 Massachusetts, USA; Vaccines Conferences Australia 2018; 12^th Annual ACTHIV, April 5 - 7, 2018, Chicago, USA; 20^th Bangkok International Conferences on HIV Medicine 2018, January 17 - 19, 2018, Bangkok, Thailand; 2^ndInternational Conferences on HIV, September 01-02, 2017 Barcelona, Spain; 21^stAnnual United States Conferences on AIDS (USCA),  September 07-09, 2017 Washington, DC, USA; 16^th European AIDS Conferences, October 25-28, 2017 Milan, Italy; Vaccines Conferences Canada 2018; Australasian  Conferences on AIDS 2017, November 06-08, 2017 Canberra,  Australia ; WAAVP 2017 - The 26^th International Conferences on Advancement of Veterinary Parasitology, September 04-08, 2017 Kuala Lumpur, Malaysia; Online conference: Vaccines: Developments and Optimization, 26-27, 2018.

Related Societies:

Europe:

European Academy of Paediatrics; European Malaria Foundation (e-malaria Foundation); European Malaria Vaccine Development (EUROMALVAC); European malaria Vaccine Initiative (EMVI)

USA:

Autism Science Foundation (ASF); Childhood Influenza Immunization Coalition (CIIC); Edward Jenner Vaccine Society; Global Polio Eradication Initiative    

Asia and Middle-East:

Lebanese Society of Allergy and Immunology; Moldavian Society of Allergology & Immunology; Moroccan Society of Allergology and Clinical Immunology

Track 13:  Hepatitis Vaccines

Hepatitis is an inflammation of the liver. The condition can be self-limiting or can progress to fibrosis (scarring), cirrhosis or liver cancer. Hepatitis viruses are the most common cause of hepatitis in the world but other infections, toxic substances (e.g. alcohol, certain drugs), and autoimmune diseases can also cause hepatitis.

There are 5 main hepatitis viruses, referred to as types A, B, C, D and E. These 5 types are of greatest concern because of the burden of illness and death they cause and the potential for outbreaks and epidemic spread. In particular, types B and C lead to chronic disease in hundreds of millions of people and, together, are the most common cause of liver cirrhosis and cancer.

Hepatitis A and E are typically caused by ingestion of contaminated food or water. Hepatitis B, C and D usually occur as a result of parenteral contact with infected body fluids. Common modes of transmission for these viruses include receipt of contaminated blood or blood products, invasive medical procedures using contaminated equipment and for hepatitis B transmission from mother to baby at birth, from family member to child, and also by sexual contact.

Acute infection may occur with limited or no symptoms, or may include symptoms such as jaundice (yellowing of the skin and eyes), dark urine, extreme fatigue, nausea, vomiting and abdominal pain.

Related Vaccines Conferences | Immunology Conferences | World Vaccine Congress

5^th World Conferences on Hepatitis & Liver Diseases, August 10-12, 2017 London, UK; 12^th Euro-Global Gastroenterology Conferences, September 11-12, 2017 Paris, France; Vaccines Conferences USA 2018 2^nd International Conferences on Digestive Diseases, December 07-08, 2017 Madrid, Spain; 12th International Conferences on Abdominal Endoscopy, April 10-12, 2018 Amsterdam, Netherlands; Vaccines Conferences Asia 2018; 2^nd International Conferences on Digestive Diseases, December 07-08, 2017 Madrid, Spain; 20^th International Conferences on Viral Hepatitis and Liver Disease, May 14-15, 2018 London, UK; International Conferences on Hepatology 2018 January 15-16, 2018 Paris, France; 11^th Australasian Conferences on Viral Hepatitis, 13-15 August 2018 Adelaide, Australia; AFRAVIH 2018: Vaccines Conferences Middle east 2018; 9^th edition of the International Francophone Conferences on Hepatitis, April 4 -7 2018 Paris, France; The European Conferences on Clinical Microbiology and Infectious Diseases, April 21-24, 2018 Madrid, Spain; ICID 2018; Vaccines Conferences Australia 2018; 20th International Conferences on Infectious Diseases, January 29-30, 2018 Sydney, Australia; Twelfth Annual Conference on Infectious Diseases Update for Primary Care and Hospital Medicine, September 14-15, 2017 Baltimore, USA; World Conferences on Hepatitis 2017, November 1-3 2017, São Paulo, Brazil; Vaccines Conferences Canada 2018; 24^th International Conferences on Hepatitis C Virus and Related Viruses (HCV 2017), September 25-28, 2017 Cape Cod, USA; Online conference: Vaccines: Developments and Optimization, 26-27, 2018.

Related Societies:

Europe:

British Society for Immunology; Microbiology Society, London; Society for Applied Microbiology; European Society of Clinical Microbiology and Infectious Diseases

USA:

The Federation of Clinical Immunology Societies; The American Association of Immunologists; American Society for Microbiology; Colombian Allergy, Asthma and Immunology Association; Canadian Society for Immunology

Asia and Middle-East:

Indian society of Allergy, Asthma and Clinical Immunology; Australasian Society of Clinical Immunology and Allergy; Bangladesh Society of Allergy and Immunology

Track 14: DNA Vaccines

DNA vaccination is a technique for protecting an animal against disease by injecting it with genetically engineered DNA so cells directly produce an antigen, resulting in a protective immunological response.

Vaccination consists of stimulating the immune system with an infectious agent, or components of an infectious agent, modified in such a manner that no harm or disease is caused, but ensuring that when the host is confronted with that infectious agent, the immune system can adequately neutralize it before it causes any ill effect. For over a hundred years vaccination has been effected by one of two approaches: either introducing specific antigens against which the immune system reacts directly; or introducing live attenuated infectious agents that replicate within the host without causing disease synthesize the antigens that subsequently prime the immune system.

The field of DNA vaccination is developing rapidly. Vaccines currently being developed use not only DNA, but also include adjuncts that assist DNA to enter cells, target it towards specific cells, or that may act as adjuvants in stimulating or directing the immune response. Ultimately, the distinction between a sophisticated DNA vaccine and a simple viral vector may not be clear. Many aspects of the immune response generated by DNA vaccines are not understood. However, this has not impeded significant progress towards the use of this type of vaccine in humans, and clinical trials have begun.

Related Vaccines Conferences | Immunology Conferences | World Vaccine Congress

6^th World Conferences on HIV/AIDS, STDs & STIs, October 29-30 Madrid, Spain; 29^thInternational Conferences on Vaccines and Immunization, March 19-20, 2018 London, UK; Vaccines Conferences USA 2018; 9th European Immunology Conferences, June 14-16, 2018 Rome, Italy; Vaccines Conferences Asia 2018; 2^nd International Conferences on Autoimmunity, November 06-07, 2017 Frankfurt, Germany; 11^thInternational Conferences on Allergy, Asthma & Clinical Immunology, September 07-08, 2017 Edinburgh, Scotland; International Conferences on Hepatology 2018 January 15-16, 2018 Paris, France; Vaccines Conferences Australia 2018;  Vaccines Conferences Middle east 2018; 11^th Australasian Conferences on Viral Hepatitis, 13-15 August 2018 Adelaide, Australia; AFRAVIH 2018: 9^th edition of the International Francophone Conferences on Hepatitis, April 4 -7 2018 Paris, France; The European Conferences on Clinical Microbiology and Infectious Diseases, April 21-24, 2018 Madrid, Spain; ICID 2018; 20th International Conferences on Infectious Diseases, January 29-30, 2018 Sydney, Australia; Vaccines Conferences Canada 2018; Twelfth Annual Conference on Infectious Diseases Update for Primary Care and Hospital Medicine, September 14-15, 2017 Baltimore, USA; World Conferences on Hepatitis 2017, November 1-3 2017, São Paulo, Brazil; 24^th International Conferences on Hepatitis C Virus and Related Viruses (HCV 2017), September 25-28, 2017 Cape Cod, USA; Online conference: Vaccines: Developments and Optimization, 26-27, 2018.

Related Societies:

Europe:

Albanian Society of Allergology and Clinical Immunology; Austrian Society of Allergology and Immunology; Belgian Society of Allergy and Clinical Immunology; British Society of Allergy and Clinical Immunology

USA:

Argentine Association of Allergy and Immunology; Argentine Society of Allergy and Immunology; Brazilian Society of Allergy and Immunology; Chilean Society of Allergy and Immunology

 Asia and Middle-East:

Allergy & Immunology Society of Sri Lanka; Allergy and Clinical Immunology Society of Singapore; Allergy and Immunology Society of Thailand

Track 15: Mucosal vaccines

Most infectious agents enter the body at mucosal surfaces and therefore mucosal immune responses function as a first line of defence. Protective mucosal immune responses are most effectively induced by mucosal immunization through oral, nasal, rectal or vaginal routes, but the vast majority of vaccines in use today are administered by injection. Immunisation involves the delivery of antigens to the mucosal immune system (dispersed or organised into units such as Peyer’s patches in the intestine or the nasal-associated lymphoid tissue in the oropharangeal cavity). The antigen delivery systems may comprise a simple buffer solution with/without adjuvants or an advanced particulate formulation, such as liposomes or nanoparticles. The most commonly evaluated route for mucosal antigen delivery is oral, but other routes have also been explored.

Related Vaccines Conferences | Immunology Conferences | World Vaccine Congress

20^th International Conferences on Neonatology and Perinatology, December 04-06, 2017 Madrid, Spain; 15^thInternational  Conferences on Pediatric Cardiology, February 19-20, 2018 Paris, France; 20^thInternational Conferences on Pediatrics Primary Care, September 03-04, 2018 Zurich, Switzerland; Vaccines Conferences USA 2018; 3^rd International Conferences on Pediatric Surgery, May 07-08, 2018 Frankfurt, Germany; 14^th International Conferences on Clinical Pediatrics, June 14-16, 2018 Rome, Italy; Vaccines Conferences Asia 2018; 11^th European Conferences on Breast Cancer (EBCC-11), March 21-23, 2018 Barcelona, Spain; Vaccines Conferences Middle east 2018; 35^thAnnual Miami Breast Cancer Conferences, March 8-11, 2018 Florida, USA; A Matter of Life or Death: From Basic Cell Death Mechanisms to Novel Conferences on Cancer Treatments, February 1- 3, 2018, Amsterdam, Netherlands; Radiation Break-through: from DNA damage responses to precision Conferences on cancer therapy, March 12 – 14, 2018 Oxford, UK; Molecular Pathology Approach to Cancer, Amsterdam, Netherlands, 4 - 6 June 2018; Vaccines Conferences Australia 2018; 25^th Biennial Conferences on Cancer Research, 30-03 July 2018 Amsterdam, Netherlands; World Conferences on Cancer, October 1-4 2018 Kuala Lumpur, Malaysia; Conferences on Cancer Immunotherapy: Combinations (C5), March 23-27, 2018, Québec, Canada; ESMO 2017 Congress-Integrating science into oncology for a better patient outcome, September 08-12 2017 Madrid, Spain; Vaccines Conferences Canada 2018; 37^th Annual Conferences on Pregnancy, January 23 - 28, 2017 Las Vegas, USA; Online conference: Vaccines: Developments and Optimization, 26-27, 2018.

Related Societies:

Europe:

Swiss Society for Microbiology; Federation of European Microbiological Societies; International Society of Vaccines; International Union of Immunological Society

USA:

Ecuadorian Society of Allergy, Asthma, and Immunology; Guatemalan Allergy, Asthma and Clinical Immunology Association; Honduran Society of Allergy and Clincial Immunology

Asia and Middle-East:

Indonesian Society of Allergy and Immunology; Korean Academy of Asthma, Allergy and Clinical Immunology; Malaysian Society of Allergy and Immunology

Track 16: Plant-based vaccines

Plant-based vaccines are recombinant protein subunit vaccines. Ideally, the choice of plant species used to produce the selected antigen should allow for oral drug delivery in the form of an edible vaccine. To date, the most advanced human vaccine projects have successfully completed phase I clinical trials, and animal vaccine projects have given promising data in early phase trials targeting specific animal species.

The plant-based vaccine production method works by isolating a specific antigen protein, one that triggers a human immune response from the targeted virus. A gene from the protein is transferred to bacteria, which are then used to “infect” plant cells. The plants then start producing the exact protein that will be used for vaccinations. The flexibility of the plant expressed vaccine system, combined with its low cost and ability to massively scale may provide vaccine protection not only to citizens of the United States, but to many parts of the world that cannot currently afford vaccines. Other uses of plant expressed vaccines including the successful creation of edible bananas that protect against the Norwalk virus.

Related Vaccines Conferences | Immunology Conferences | World Vaccine Congress

6^th Euro-Global Conferences on Infectious Diseases, September 7-9, 2017 Paris, France; 5^th  International Conferences on Infectious Diseases, March 1-2, 2018 Berlin, Germany; 4^th World Conferences on Rare Diseases and Orphan Drugs, June 11-12, 2018 Dublin, Ireland; Vaccines Conferences USA 2018; International Conferences on Emerging Infectious Diseases, 31^st August-1^st September 2018 Zurich, Switzerland; 6^th World Conferences on HIV/AIDS, STDs & STIs, October 29-30 Madrid, Spain; Vaccines Conferences Asia 2018; 13^th World Conferences on Infection Prevention and Control, December 14-16, 2017 Rome, Italy; 11^th European Conferences on Breast Cancer (EBCC-11), March 21-23, 2018 Barcelona, Spain; Vaccines Conferences Middle east 2018; 35^thAnnual Miami Breast Cancer Conferences, March 8-11, 2018 Florida, USA; A Matter of Life or Death: From Basic Cell Death Mechanisms to Novel Conferences on Cancer Treatments, February 1- 3, 2018, Amsterdam, Netherlands; Radiation Break-through: from DNA damage responses to precision Conferences on cancer therapy, March 12 – 14, 2018 Oxford, UK; Vaccines Conferences Australia 2018; Molecular Pathology Approach to Cancer, Amsterdam, Netherlands, 4 - 6 June 2018; 25^th Biennial Conferences on Cancer Research, 30-03 July 2018 Amsterdam, Netherlands; World Conferences on Cancer, October 1-4 2018 Kuala Lumpur, Malaysia; Conferences on Cancer Immunotherapy: Combinations (C5), March 23-27, 2018, Québec, Canada; Vaccines Conferences Canada 2018;  ESMO 2017 Congress-Integrating science into oncology for a better patient outcome, September 08-12 2017 Madrid, Spain; 37^th Annual Conferences on Pregnancy, January 23 - 28, 2017 Las Vegas, USA; Online conference: Vaccines: Developments and Optimization, 26-27, 2018.

Related Societies:

Europe:

Croatian Society of Allergology and Clinical Immunology; Czech Society of Allergology and Clinical Immunology; Finnish Society of Allergology and Clinical Immunology; French Society of Allergology and Clinical Immunology

USA:

Panamanian Association of Allergology and Clinical Immunology; Paraguayan Society of Allergy, Asthma, and Immunology; Peruvian Society of Allergy and Immunology; Venezuelan Society of Allergy, Asthma and Immunology

Asia and Middle-East:

Philippine Society of Allergy, Asthma and Immunology; Taiwan Academy of Pediatric Allergy Asthma Immunology; Vietnam Association of Allergy, Asthma and Clinical Immunology

Track 17: HPV Vaccines

Human Papillomavirus (HPV) vaccine is an inactivated (not live) vaccine which protects against four major types of HPV.

These include two types that cause about 70% of cervical cancer and two types that cause about 90% of genital warts. HPV vaccine can prevent most genital warts and most cases of cervical cancer. Protection from HPV vaccine is expected to be long-lasting. But vaccinated women still need cervical cancer screening because the vaccine does not protect against all HPV types that cause cervical cancer.

Routine HPV Vaccination                                           

• HPV vaccine is routinely recommended for girls 11 and 12 years of age
• The HPV4 vaccine (the type recommended for prevention of genital warts in girls) may also be given in three doses to boys aged 9 to 26.

It is important for girls to get HPV vaccine before their first sexual contact -- because they have not been exposed to HPV.  For these girls, the vaccine can prevent almost 100% of disease caused by the four types of HPV targeted by the vaccine. However, if a girl or woman is already infected with a type of HPV, the vaccine will not prevent disease from that type. The vaccine is also recommended for girls and women 13 through 26 years of age who did not receive it when they were younger.

Related Vaccines Conferences | Immunology Conferences | World Vaccine Congress

10^th International Virology Conferences and Expo, July 02-04, 2018 Vienna, Austria; 8^th Global Conferences on Microbiology & Infectious Diseases, February 22-23, 2018 Paris, France; 16^th International Conferences on Pharmaceutical Microbiology and Biotechnology, May 21-23, 2018 Vienna, Austria; Vaccines Conferences USA 2018; 4^th  Conferences on Applied Microbiology, November 29-December 01, 2017 Madrid, Spain; 8^th Clinical Microbiology Conferences, October 26-28, 2017 Paris, France; Vaccines Conferences Asia 2018; 46^th World Conferences on Microbiology, September 18-19, 2017 Dublin, Ireland; 13th World Conferences on Healthcare & Technologies, June 14-15, 2018 Dublin, Ireland; A Matter of Life or Death: From Basic Cell Death Mechanisms to Novel Cancer Treatments Conferences, February 1- 3, 2018, Amsterdam, Netherlands; Vaccines Conferences Middle east 2018;  Radiation Break-through: from DNA damage responses to precision Conferences on cancer therapy, March 12 – 14, 2018 Oxford, UK; Molecular Pathology Approach to Cancer, Amsterdam, Netherlands, 4 - 6 June 2018; Vaccines Conferences Australia 2018;  25^th Biennial Conferences on Cancer Research, 30-03 July 2018 Amsterdam, Netherlands; World Conferences on Cancer, October 1-4 2018 Kuala Lumpur, Malaysia; Conferences on Cancer Immunotherapy: Combinations (C5), March 23-27, 2018, Québec, Canada; Vaccines Conferences Canada 2018;  Conferences on oncology, September 08-12 2017 Madrid, Spain; Online conference: Vaccines: Developments and Optimization, 26-27, 2018.

Related Societies:

Europe:

Slovenian Association for Allergology & Clinical Immunology; Spanish Society of Allergology and Clinical Immunology; European Federation for Immunogenetics; European Macrophage and Dendritic Cell Society

USA:

American Association of Immunologists; American Association of Pharmaceutical Scientists; American Association of Veterinary Immunologists; American Society for Histocompatibility and Immunogenetics

Asia and Middle-East:

Israel Association of Allergy and Clinical Immunology; Jordanian Society for Allergy and Clinical Immunology; Kuwait Society of Allergy & Clinical Immunology; Japanese Society for Immunology, Japan; Singaporean Society For Immunology, Singapore; Australasian Society of Clinical Immunology and Allergy, Australia

Track 18: Travel Immunization

Anyone planning to travel abroad may need immunizations before departure. Although few immunizations are compulsory for international travel, some are recommended for the traveller’s protection. Some vaccines must be given in 2–3 doses several weeks apart. Therefore, a doctor should be consulted at least 2–3 months before departure. Children under 1 year, and people with a compromised immune system or serious underlying disorder may not be able to have some vaccinations, such as those for yellow fever and tuberculosis (BCG). Recommended vaccines are travel vaccinations that can protect you in areas where there is an intermediate or high risk for contracting certain illnesses. They also help prevent the spread of diseases from one country to another.

Related Vaccines Conferences | Immunology Conferences | World Vaccine Congress

20^th International Conferences on Neonatology and Perinatology, December 04-06, 2017 Madrid, Spain; 15^thInternational Conferences on Pediatric Cardiology, February 19-20, 2018 Paris, France; Vaccines Conferences USA 2018; 20^thInternational Conferences on Pediatrics Primary Care, September 03-04, 2018 Zurich, Switzerland; 3^rd International Conferences on Pediatric Surgery, May 07-08, 2018 Frankfurt, Germany; 14^th International Conferences on Clinical Pediatrics, June 14-16, 2018 Rome, Italy; Vaccines Conferences Asia 2018; 18^thInternational Conferences on Infectious Diseases, March 1-4, 2018 Buenos, Argentina; The European Conferences on Clinical Microbiology and Infectious Diseases, April 21-24, 2018 Madrid, Spain; ICID 2018; Vaccines Conferences Middle east 2018; 20th International Conference on Infectious Diseases, January 29-30, 2018 Sydney, Australia; Twelfth Annual Conferences on Infectious Diseases Update for Primary Care and Hospital Medicine, September 14-15, 2017 Baltimore, USA; Vaccines Conferences Australia 2018;  30^th Annual Conferences on Infectious Diseases in Children, November 18-19, 2017 New York, USA; Conferences on Infectious Diseases: Adult Issues in the Outpatient and Inpatient Settings, April 02-06, 2018 Florida, USA; Vaccines Conferences Canada 2018; ID Week 2017 Infectious Diseases Conferences, October 4-7, 2017 California, USA; 10^th conferences on Pediatric Infectious Diseases (WSPID), December 2-5, 2017 Shenzhen, China; Online conference: Vaccines: Developments and Optimization, 26-27, 2018.

Related Societies:

Europe:

European Society for Immunodeficiency; French Society of Immunology; Immunology of Diabetes Society; Deutsche Gesellschaft für Immunologie

USA:

American Academy of Paediatrics (AAP); American College Health Association (ACHA); Association of Immunization Managers (AIM); Association for Professionals in Infection Control and Epidemiology (APIC)

Asia and Middle-East:

Asia Pacific Association of Allergy, Asthma, and Clinical Immunology (APAAACI); Asia Pacific Association of Pediatric Allergy, Respirology and Immunology (APAPARI); Commonwealth of Independent States Society of Allergology and Immunology (CIS Society)

Track 19: Vaccines for Vector-borne Diseases

Vaccines that target blood-feeding disease vectors, such as mosquitoes and ticks, have the potential to protect against the many diseases caused by vector-borne pathogens. Vector-borne diseases are among the most complex of all infectious diseases to prevent and control. Vector- borne diseases, most of which are transmitted in and around the home, are best controlled by a combination of vector control (use of public health insecticides on bednets, or by spraying), medicines and vaccines.

Historically, successful vector-borne disease prevention resulted from management or elimination of vector populations.  Malaria was driven out of the USA and most of Europe in this way. Where vector control has been consistently applied in the past, the results have been dramatic, especially with early efforts to control malaria by spraying the inside surfaces of houses with insecticides. Indoor Residual Spraying (IRS) and long-lasting insecticide treated bednets have been very effective over the last 10 years and are widely regarded as one of the main contributors to the more than 1 million lives saved.

In contrast to expenditure and effort on medicine, diagnostic and vaccine development, relatively little attention was given to vector control in the past.  The foresighted establishment of IVCC in 2005, with a grant from the Bill and Melinda Gates Foundation began the process of bringing Vector Control into the mainstream strategy for future eradication of malaria and other vector-borne diseases.

Related Vaccines Conferences | Immunology Conferences | World Vaccine Congress

5^th World Conferences on Hepatitis & Liver Diseases, August 10-12, 2017 London, UK; 12^th Euro-Global Gastroenterology Conferences, September 11-12, 2017 Paris, France; Vaccines Conferences USA 2018;  2^nd International Conferences on Digestive Diseases, December 07-08, 2017 Madrid, Spain; 12th International Conferences on Abdominal Endoscopy, April 10-12, 2018 Amsterdam, Netherlands; 2^nd International Conferences on Digestive Diseases, December 07-08, 2017 Madrid, Spain; Vaccines Conferences Asia 2018; 22^nd International AIDS Conferences (AIDS 2018) July 23-27 2018 Amsterdam, Netherlands; CHA 2018; 20^thInternational Conferences on HIV and AIDS, May 14 - 15, 2018 London, UK; Vaccines Conferences Middle east 2018; The annual Conferences on Retroviruses and Opportunistic Infections (CROI), March 4 -7, 2018 Massachusetts, USA; 12^th Annual ACTHIV, April 5 - 7, 2018, Chicago, USA; 20^th Bangkok International Conferences on HIV Medicine 2018, January 17 - 19, 2018, Bangkok, Thailand; Vaccines Conferences Australia 2018; 2^ndInternational Conferences on HIV, September 01-02, 2017 Barcelona, Spain; 21^stAnnual United States Conferences on AIDS (USCA),  September 07-09, 2017 Washington, DC, USA; Vaccines Conferences Canada 2018; 16^th European AIDS Conferences, October 25-28, 2017 Milan, Italy; Australasian  Conferences on AIDS 2017, November 06-08, 2017 Canberra,  Australia; Online conference: Vaccines: Developments and Optimization, 26-27, 2018.

Related Societies:

Europe:

European Academy of Allergy and Clinical Immunology (EAACI); European Molecular Biology Laboratory (EMBL);  Medical Research Council (MRC) 

USA:

Hepatitis B Foundation (HBF); Infectious Diseases Society of America (IDSA); National Adult and Influenza Immunization Summit (NAIIS); National Foundation for Infectious Diseases (NFID); Paediatrics Infectious Diseases Society (PIDS)

Asia and Middle-East:

Russian Association of Allergology and Clinical Immunology; Turkish National Society of Allergy and Clinical Immunology; Ukrainian Association of Allergologists and Clinical Immunologists

Track 20: Tuberculosis Vaccines

BCG, or bacille Calmette-Guerin (Tuberculosis Vaccines), is a vaccine for tuberculosis (TB) disease. Many foreign-born persons have been BCG-vaccinated. BCG is used in many countries with a high prevalence of TB to prevent childhood tuberculous meningitis and miliary disease. However, Tuberculosis Vaccine is not generally recommended for use in the United States because of the low risk of infection with Mycobacterium tuberculosis, the variable effectiveness of the vaccine against adult pulmonary TB, and the vaccine’s potential interference with tuberculin skin test reactivity. The Tuberculosis Vaccine should be considered only for very select persons who meet specific criteria and in consultation with a TB expert.

Related Vaccines Conferences | Immunology Conferences | World Vaccine Congress

6^th World Conferences on HIV/AIDS, STDs & STIs, October 29-30 Madrid, Spain; 29^thInternational Conferences on Vaccines and Immunization, March 19-20, 2018 London, UK ; Vaccines Conferences USA 2018; 9th European Immunology Conferences, June 14-16, 2018 Rome, Italy; Vaccines Conferences Canada 2018; 2^nd International Conferences on Autoimmunity, November 06-07, 2017 Frankfurt, Germany; 11^thInternational Conferences on Allergy, Asthma & Clinical Immunology, September 07-08, 2017 Edinburgh, Scotland; Vaccines Conferences Asia 2018; 4^th ESCMID Conferences on Vaccines, September 8-10, 2017 Dubrovnik, Croatia; 2017 International Society for Vaccines Annual Conference, October 5-7, 2017 Paris, France; Conferences on Vaccines Research & Development, November 20-22, 2017, Valencia, Spain; 2^nd Global Conferences on Vaccines Research, March 19-20, 2018 London, UK; Vaccines Conferences Middle east 2018; World Vaccines ConferencesWashington 2018, April 3-5, 2018 Washington DC, USA; Global Conferences on Vaccines and Vaccination Techniques, April 16-18, 2018, Dubai, UAE; 4^th  Global Conferences on Virology and Vaccines, April 19-21, 2018 Valencia, Spain; Vaccines Conferences Australia 2018; 48^th National Immunization Conferences, May 15-17, 2018 Atlanta, USA; Conferences on Vaccines Technology, June 17-22, 2018 Quebec, Canada; Conferences on HIV Research for prevention October 21-25, 2018 Madrid, Spain; Online conference: Vaccines: Developments and Optimization, 26-27, 2018.

Related Societies:

Europe:

British Society for Allergy and Clinical Immunology; British Society for Histocompatibility and Immunogenetics; European Federation of Immunological Societies; European Academy of Allergology and Clinical Immunology

USA:

Voices For Vaccines (VFV); National Institute of Allergy and Infectious Disease (NIAID); American Public Health Association (APHA); American Association for the Advancement of Science (AAAS); American Society for Microbiology (ASM)

Asia and Middle-East:

Australasian Society for Immunology; Australasian Society of Clinical Immunology and Allergy; Israel Association of Allergy and Clinical Immunology; Jordanian Society for Allergy and Clinical Immunology; Japanese Society for Immunology, Japan

Latest Scope, Research and Innovation in Vaccines

Vaccines Companies

Vaccines Companies in Europe: Hookipa Biotech | s-TARget Therapeutics | Valneva | GlaxoSmithKline | AXON Neuroscience | Bavarian Nordic | Onxeo | Vibalogics | BioNTech | Immatics Biotechnologies | MSD (Merck) | Okairos | Bilthoven Biologicals | ISA Pharmaceuticals | Ferrer | 2A Pharma | Anergis | Amal Therapeutics | AFFiRiS | Themis Bioscience | DanDrit Biotechnology | Abivax | InnaVirVax | APCure | Imaxio | Vaxon Biotech | VitamFero | Theravectys | Bial | Aelix Therapeutics | Mymetics | Treos Bio | Prokarium | Glide Technologies | Midatech | PsiOxus Therapeutics | ImmunoBiology (ImmBio) | Seqirus (CSL) | Scancell | Allergy Therapeutics

Vaccines Companies in USA:  IGNITE Immunotherapy | Dynavax Technologies | Novartis Diagnostics | Entest Biomedical | ImmunoScience | Inovio Pharmaceuticals | MediGene | Novartis | Pfene | Vical | Pfizer | Celldex Therapeutics | Protein Sciences | Opko Health | GeneCure Biotechnologies | CSL Behring | Akorn | Antera Therapeutics | Matrivax Research & Development | Merck | Affinivax | Genocea Bioscience | Sanofi Pasteur | VBI Vaccines | Berg | Agenus | Xenetic Biosciences | Selecta Biosciences | PharmAthene | Medigen | MedImmune (AstraZeneca) | Altimmune | Emergent Biosolutions | Biologics Resources | Integrated BioTherapeutics | Sanaria | Wellstat Group | NanoBio | Takeda Vaccines | Liquidia Technologies | NovaDigm Therapeutics| Immunotope | Immunovaccine | Bellicum Pharmaceuticals | Cascadian Therapeutics  | EpiThany | Etubics | Immune Design | Akshaya BIO | InterveXion Therapeutics | Cascadian Therapeutics | Etubics | Immune Design | InterveXion Therapeutics | Gritstone Oncology | SutroVax  | CardioVax | Tolerion | PaxVax | Adamis Pharmaceuticals | BioMedicure | MabVax Therapeutics | Polynoma | Galena Biopharma | Meissa Vaccines | Vaxart | Altravax | ImmunoCellular Therapeutics | Sinovac Biotech | Vivaldi Biosciences | EpitoGenesis | Nanotherapeutics | TapImmune | Aurora Biopharma | GeoVax | Inhibikase Therapeutics | TremRx | Immudicon | ImmusanT | Neon Therapeutics | Alopexx Vaccine (Alopexx) | OncoPep | Antigen Express (Generex Biotechnology) | PathoVax | Biofactura | Biological Mimetics | Neuralstem | Immunomic Therapeutics | SynAm Vaccine | Immunophotonics  | Sequoia Sciences | Heat Biologics | Annias Immunotherapeutics | Advaxis | Agilvax | Codagenix | United Biomedical | Intellect Neurosciences | Alpha-1 Biologics | TechnoVax | PnuVax | IgY Immune Technologies & Life Sciences | Najit Technologies | UbiVac | Avax Technologies | Molecular Targeting Technologies (MTTI) | Vitruvian Biomedical | TRIA Biosciences | FluGen | Madison Vaccines

Vaccines Companies in Asia & Middle-East: Bharat Biotech | Indian Immunologicals | Shantha (Sanofi) | Panacea Biotec | Adimmune (Taichung) | Medigen Vaccine Biologics | Lipotek | Admedus | Gamma Vaccines | Sementis | BioDiem | Vaxxas Nanopatch | Sinovac Biotech | Haffkine Biopharmaceuticals | Sentinext Therapeutics | Rhapsody Biologics

List of Vaccines

Adenovirus vaccine | Alzheimer's disease amyloid protein vaccine | Bacterial diseases Vaccines  | BCG vaccine | Breast cancer vaccine | Cancer Vaccine | Caries vaccine | Chagas disease vaccine | Cholera vaccine | Coxsackie B virus vaccine | Cytomegalovirus vaccine | Dengue vaccine  | Diphtheria-Tetanus toxoids (DT-dT) | Diphtheria-Tetanus-wPertussis vaccine (DTwP)  | DPT vaccine | DTaP vaccine | DTwP-Hep B vaccine | DTwP-HepB-Hib vaccine | DTwP-Hib vaccine | DTwP-IPV | DTwP-IPV-Hep B vaccine | DTwP-IPV-Hep B-Hib vaccine | Eastern Equine encephalitis virus vaccine | Ebola vaccine | Ehrlichiosis vaccine | Enterovirus 71 vaccine | Epstein–Barr vaccine | Haemophilus influenzae type b vaccine | Hepatitis A vaccine | Hepatitis B vaccine | Hepatitis C vaccine | Hepatitis E vaccine | Hib vaccine | HIV vaccine | Hookworm vaccine | HPV vaccine | HTLV-1 T-lymphotropic leukemia vaccine | Influenza vaccine | IPV | Japanese encephalitis vaccine | Leprosy vaccine | Lyme disease vaccine | Malaria vaccine | Marburg virus disease vaccine | Measles vaccine |  Measles-Mumps-Rubella vaccine (MMR) | Measles-Rubella vaccine (MR) | Meningococcal A+C +W polysaccharide vaccine | Meningococcal A+C polysaccharide vaccine | Meningococcal conjugate vaccine | Meningococcal vaccine | MMR vaccine | MMRV vaccine | Mumps vaccine | Norovirus vaccine | Onchocerciasis river blindness vaccine | OPV | Oral Cholera vaccine | Ovarian cancer vaccine | Pertussis vaccine | Pneumococcal conjugate vaccine | Pneumococcal polysaccharide vaccine | Polio vaccine | Prostate cancer vaccine | Q fever vaccine | Rabies vaccine | Respiratory syncytial virus vaccine | Rotavirus vaccine | Rubella vaccine | Schistosomiasis vaccine | Severe acute respiratory syndrome Vaccine (SARS) | Shingles Vaccine | Smallpox vaccine | Staphylococcus aureus vaccine | Streptococcus pyogenes vaccine | Syphilis vaccine | Tetanus Toxoid vaccine (TT) | Trypanosomiasis vaccine | Tuberculosis Vaccine (BCG) | Tularemia vaccine | Typhoid vaccine | Varicella vaccine | Shingles vaccine | MMRV vaccine | Visceral leishmaniasis vaccine | West Nile virus vaccine for humans | Yellow fever vaccine | Yersinia pestis vaccine | Zika fever Vaccine;

Vaccines Journals

Asian Journal of Infectious Diseases | Biotechnology Advances | Cellular Immunology | Clinical and Experimental Vaccine Research | Clinical and Vaccine Immunology | Clinical Infectious Diseases | Expert Review of Vaccines | Human Vaccines and Immunotherapeutics | Immunology Letters | International Journal of Collaborative Research on Internal Medicine & Public Health | International Journal of Vaccines and Immunization | International Journal of Vaccines and Research | Journal of Allergy and Clinical Immunology | Journal of Immunological Techniques in Infectious Diseases | Journal of Vaccines & Clinical Trials | Journal of Vaccines & Vaccination | Journal of Veterinary Medical Education | Journal of Veterinary Medical Science | Journal of Veterinary Pharmacology and Therapeutics | Journal of Virological Methods | Molecular Immunology | npj Vaccines | Open Vaccine Journal | Pediatric Infection and Vaccine | Public Health | The Journal of Pediatrics | The Journal of Pediatrics | The Lancet | The Pediatric Infectious Diseases | Therapeutic Advances in Vaccines | Trials in Vaccinology | Vaccimonitor | Vaccines |  Veterinary Clinical Pathology | Veterinary Immunology and Immunopathology | Veterinary Microbiology | Virology | World Journal of Vaccines | African Journal of AIDS Research | Annual Review of Immunology | Archives of Pediatric Infectious Diseases | Cancer Immunology, Immunotherapy | Current HIV Research | European Journal of Immunology |  Immunological Reviews | International Immunology | Iranian Journal of Immunology | Journal of AIDS and Clinical Research | Journal of Clinical Immunology | Journal of Immunology | Journal of Infectious Diseases | Journal of Travel Medicine | Journal of Virology | Microbiology and Immunology | OncoImmunology | Open Immunology Journal | Open Infectious Diseases Journal | The Lancet Infectious Diseases | The Lancet HIV | Therapeutic Advances in Infectious Disease| Ticks and Tick-borne Diseases | Tropical Medicine and Health | Viral Immunology

                      Vaccines Conferences Committee invites all the participants across the world to attend “31^st Euro Global Summit and Expo on Vaccines & Vaccination” going to be held during June 14-16, 2018 in Barcelona, Spain. The Theme of the conference is "Roadmap on the future of Vaccines Research" will explore the advances in Vaccines and vaccination.

Importance & Scope:

This conference could be an exceptional event that brings along a novel and International mixture of huge and medium cognizance on vaccines and vaccination, leading universities engendering the conference an ideal platform to apportion expertise, foster collaborations across trade and world, and assess elevating technologies across the world.

Vaccination is a key to eradicate the diseases. It is a subject for the professionals who looks beyond the clinical prospects. Traditional approaches to vaccine design were to emasculate or inactivate the human pathogen or a cognate animal homologue, Vaccinology is the science of vaccine development and how the immune system responds to vaccines, but additionally includes perpetual evaluation of immunization programs and vaccine safety and efficacy, as well as surveillance of the epidemiology of vaccine-preventable diseases. This chapter provides a brief overview of some of the main concepts of immunology and Vaccinology as they relate to immunization. Euro Vaccines 2018 amasses all the extroverts under one roof of current advances.

Why Barcelona?

Spain’s second largest and definitely most cosmopolitan city, and one of the Mediterranean’s busiest ports. Barcelona is the capital of Catalonia, which is a region of Spain with its own language – Catalan, and its own culture and character. Barcelona is known throughout the world as a cultural city with considerable heritage and a permanent, dynamic offer, a rich architectural and monumental heritage with works that have been declared part of the world heritage by the UNESCO.

This city has the greatest concentration of top class universities in the world. The presence of universities, hospitals, labs and other professional services, together with key installations make it favourite destination for scientific meetings.

Hospitals Associated with Vaccines Research

Barcelona

• Hospital of Barcelona
• Hospital of Sant Pau
• Hospital Vall d’Hebron
• Hospital of Bellvitge
• Hospital del Mar
• Hospital Clinic of Barcelona
• Hospital Quirónsalud Barcelona
• Antonio Campoy SLU
• Artro Esport SL
• Artroscopia GC
• Barcelona Spine Center
• Centre Cardiovascular Sant Jordi
• Centre Medic Medibaix
• Centre Medic Sant Jordi de Sant Andreu
• Centre Medico Tecno
• Centre de Ginecologia I Obstetricia
• Centro Medico Teknon
• Centro de Diagnóstico por imagen foraste S.A.
• Centro de Oftalmología Barraquer S.A.
• Ciscar Laboratori SA
• Clinic Barcelona
• Clinica Baviera Barcelona
• Clinica Claros
• Clinica Diagonal-Clinica de Medicina Integral
• Clinica MAZ (Sant Honorat)
• Clinica Nuestra Senora Del Remedio
• Clinica Quiron
• Clinica Sagrada Familia
• Clinica Sant Josep
• Clinica Tres Torres
• Clinica de Vic
• EMSI - Equip Medic De Salut Integral S. L.
• Hospital Del Mar
• Hospital Quiron Barcelona
• Hospital Sant Joan de Deu
• Hospital de Sabadell
• Idonabi
• J. Sancho Serrats SL
• Laboratorio Dr F. Echevarne Analisis S.A.
• M.D.B
• Policlinica Barcelona
• Policlinica Del Valles
• USP Centro de Cirugia Ambulatoria Planetarium
• USP Instituto Oftalmologico de Barcelona
• Vall d'Hebron Hospitals
• Virgen De Nuria Centre Medic

Spain:

• Joan XXIII Hospital - Tarragona
• Hospital Santa Tecla - Tarragona
• Hospital San Joan de Reus - Reus , Tarragona
• Pius Hospital de Valls - Valls , Tarragona
• Hospital Sant Joan de Déu Barcelona Link - Esplugues de Llobregat , Barcelona
• Hospital Clínic Link - Barcelona
• Parc Taulí Corporation - Sabadell
• Hospital of Barcelona - Barcelona
• Hospital of Bellvitge - l'Hospitalet de Llobregat , Barcelona
• Hospital of the Vall d'Hebron - Barcelona
• Hospital del Mar- Barcelona
• Hospital de Sant Pau (until June 2009)
• Hospital Quirón Barcelona [2] - Barcelona
• Hospital Plató - Barcelona
• Girona Nephrology and Dialysis Service [3] - Girona
• Hospital Universitario Arnau de Vilanova - Lleida
• Hospital Infanta Cristina de Badajoz
• University Hospital Complex of A Coruña - A Coruña
• University Hospital Complex of Santiago - Santiago de Compostela
• Hospital Complex Architect Marcide - Professor Novoa Santos - Naval. Xerencia of the Area of ​​Ferrol - Ferrol
• Public Foundation Virxe da Xunqueira Hospital - Cee, Galicia
• Public Foundation Barbanza Hospital - Santa Mariña de Ribeira
• Xeral-Calde Hospital Complex - Lugo
• Hospital da Costa - Burela
• Hospital Comarcal de Monforte - Monforte de Lemos
• Pontevedra Hospital Complex - Pontevedra
• University Hospital Complex Of Vigo - Vigo
• Public Foundation Hospital do Salnés - Vilagarcía de Arousa
• Ourense Hospital Complex - Ourense
• Verín Hospital Foundation - Verín
• Hospital Comarcal de Valdeorras - Valdeorras
• Hospital San Pedro - Logroño
• Hospital 12 de Octubre
• Hospital Carlos III
• Hospital Puerta del Hierro Majadahonda, Madrid
• University Hospital La Paz
• Moncloa Clinic
• University Hospital Foundation Alcorcón
• Hospital of Móstoles - Móstoles, Madrid
• Hospital Quirón Madrid [4]
• Hospital Ramón y Cajal
• Hospital La Princesa
• Child Jesus Hospital
• Hospital Gregorio Marañón
• Dam Hospital
• Central Hospital of Defense (Military)
• University Hospital Virgen de la Arrixaca- Murcia
• University Hospital Morales Meseguer - Murcia
• University Hospital Reina Sofía [1] - Murcia
• USP Hospital San Carlos - Murcia
• University Hospital Virgen del Rosell - Cartagena
• General University Hospital of Santa Lucía - Cartagena
• Hospital Nuestra Señora del Perpetuo Socorro - Cartagena
• Hospital Naval - Cartagena
• Santo Hospital de la Caridad - Cartagena
• Virgen de la Caridad Medical Center - Cartagena
• Rafael Mendez Hospital - Lorca
• Hospital de la Vega Lorenzo Guirao - Cieza
• Hospital Comarcal del Noroeste - Caravaca de la Cruz
• Hospital Virgen del Castillo - Yecla
• Hospital Los Arcos - San Javier, Murcia
• Clinica Universitaria de Navarra Link - Pamplona
• Hospital Universitari La Fe - Valencia
• Hospital 9 d'Octubre - Valencia
• Hospital Arnau de Vilanova - Valencia
• Hospital Virgen del Consuelo - Valencia
• Vazquez Bernabeu Military Hospital - Valencia
• Nisa Hospital València al Mar - Valencia
• Doctor Peset University Hospital - Valencia
• Hospital Clínic Universitari - Valencia
• Hospital la Malva-Rosa - Valencia
• General University Hospital - Valencia
• Clinica Quirón - Valencia
• House of health - Valencia
• Hospital of Manises - Manises
• Hospital of Lliria - Lliria
• Hospital Lluis Alcanyís - Xàtiva
• Hospital Francesc de Borja - Gandia
• Hospital of La Ribera - Alzira
• General Hospital of Requena - Requena
• General University Hospital of Castellón - Castellón de la Plana
• Provincial Hospital of Castellón - Castellón de la Plana
• University Hospital of La Plana - Villareal
• Hospital Comarcal de Vinaròs - Vinaròs
• Segorbe Auxiliary Hospital - Segorbe
• Sagunto Hospital - Sagunto
• Alicante / Alacant [ edit ]
• General Hospital of Alicante - Alicante
• University Hospital San Juan de Alicante - Alicante
• General Hospital Plá - Alicante
• University Hospital San Juan - San Juan de Alicante
• General Hospital of Dénia (Marina Salud) - Dénia
• Hospital Marina Baixa - Benidorm
• University Hospital of Vinalopó - Elche
• General Hospital of Elche - Elche
• General Hospital of Elda - Elda
• Public Hospital Virgen de Los Lirios - Alcoy
• General Hospital of Ontinyent - Ontinyent
• University Hospital of Torrevieja - Torrevieja

Worldwide:

• Cleveland Clinic
• St Jude Children's Research Hospital
• Johns Hopkins Medicine                                                        
• Mayo Clinic Scottsdale AZ
• University of Maryland Medical Center
• M D Anderson Cancer Center
• Massachusetts General Hospital
• Assistance Publique Hôpitaux de Paris
• Memorial Sloan Kettering Cancer Center
• New York Presbyterian / Lower Manhattan Hospital
• Providence Health & Services
• Deer's Head Hospital Center
• Buddhist Tzu Chi General Hospital
• Beth Israel Deaconess Medical Center Needham     
• Aurora Health Care
• Taipei Veterans General Hospital
• Advocate Health Care
• University of Pittsburgh Medical Center
• Brigham and Women's Hospital
• Hartford Hospital

Societies Associated with Vaccine Research

Spain

• Spanish Association of Paediatrics
• Spanish Society for Immunology
• Spanish Society of Allergology and Clinical Immunology

Europe

• European Federation of Immunological societies (EFIS)
• Italian Society of Allergy, Asthma and Clinical Immunology
• German Society for Allergology and Clinical Immunology
• British Society of Allergy and Clinical Immunology
• French Society of Allergology and Clinical Immunology
• Dutch Society of Allergology
• Romanian Society of Allergology and Clinical Immunology
• Czech Society of Allergology and Clinical Immunology

Worldwide

• The International Union of Immunological Societies
• The Society for Mucosal Immunology
• British Society for Immunology
• Federation of African Immunological Societies
• Federation of Clinical Immunology Societies
• Infectious Diseases Society of America
• Immune Deficiency Foundation
• European Federation of Immunological Societies
• Venezuelan Society of Allergy, Asthma and Immunology
• Peruvian Society of Allergy and Immunology
• Honduran Society of Allergy and Clincial Immunology
• Guatemalan Allergy, Asthma and Clinical Immunology Association
• Chilean Society of Allergy and Immunology
• Brazilian Society of Allergy and Immunology
• Argentine Society of Allergy and Immunology
• Swiss Society of Allergology and Immunology
• Slovenian Association for Allergology & Clinical Immunology
• Serbian Association of Allergologists and Clinical Immunologists
• Romanian Society of Allergology and Clinical Immunology (RSACI)
• Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC)
• celandic Society of Allergy and Clinical Immunology
• Portuguese Society of Allergology and Clinical Immunology
• Hungarian Society of Allergology and Clinical Immunology
• Hellenic Society of Allergology and Clinical Immunology
• German Society for Allergology and Clinical Immunology
• French Society of Allergology and Clinical Immunology
• Malaysian Society of Allergy and Immunology
• Australasian Society of Clinical Immunology and Allergy
• Russian Association of Allergology and Clinical Immunology
• Georgian Association of Allergology and Clinical Immunology

Industries Associated with Vaccines Research

Barcelona:

• Adienne Pharma & Biotech
• Almirall
• BCN Peptides
• Biokit
• Charles River Laboratories
• Ferrer
• Grifols
• Menarini
• Oryzon Genomics
• Veeva Systems

Spain:

• Aelix Therapeutics
• Ferrer
• Bial
• GlaxoSmithKline
• Biofabri
• Nordvacc
• Novartis vaccines and diagnostics sl.
• Cooperativa Pharmaceuticals Ciudad Real
• ANYSA GANADERA SL
• VILA PEIRO, S.A.
• Eli Lilly
• Adienne Pharma & Biotech
• Almirall
• BCN Peptides
• Biokit
• Charles River Laboratories
• Ferrer
• Grifols
• Menarini
• Oryzon Genomics
• Veeva Systems
• Bayer
• Acumed
• Genomica
• GlaxoSmithKline
• Norgine
• Pfizer
• Pharmamar (Zeltia)
• Teleflex Medical
• 3P Biopharmaceuticals
• Cinfa Biotech
• Sofpromed
• Syntax for Science
• Lonza
• Baxter
• Praxis Pharmaceutical
• Synthon
• Ipsen
• Biomedal
• Amadix
• Laboratorios IVEN

Worldwide: (Top Industries)

• Abbott Labs
• Altimmune
• BiondVax Pharma
• Dynavax Tech
• Emergent Bio
• Genocea Bio
• GlaxoSmithKline
• Heat Biologics
• Inovio Pharma
• Merck
• Novartis
• Novavax
• Opko Health
• Pfizer
• Sanofi
• Sinovac Biotech
• VBI Vaccines
• Vical Inc

Universities Associated with Vaccines Research

Barcelona:

• University of Barcelona
• Universitat Autònoma de Barcelona
• Barcelona College of Chiropractic
• Escuela Superior de MTC
• Instituto Superior de Medicinas Tradicionales
• Biodynamic Craniosacral Spanish Institute
• Instituto Erich Fromm de Psicoterapia Integradora Humanista
• Ramon Llull University
• Nacar Clínicas Dentales

Spain

• Universidad de Alcalá
• Universidad Alfonso X El Sabio
• Universitat Autònoma de Barcelona
• Universidad Autónoma de Madrid
• Universitat de Barcelona
• Universidad de Cádiz
• Universidad de Cantabria
• Universidad de Castilla-La Mancha
• Universidad de Castilla-La Mancha
• Valencia Catholic University Saint Vincent Martyr
• CEU San Pablo University
• Universidad CEU Cardenal Herrera
• Universidad Complutense de Madrid
• Universidad de Córdoba
• University of the Basque Country
• Universidad Europea de Madrid
• Universidad de Extremadura
• Universidad Francisco de Vitoria
• Universitat de Girona
• Universidad de Granada
• Universitat Internacional de Catalunya
• Universidad de La Laguna
• Universidad de Las Palmas de Gran Canaria
• Universitat de Lleida
• Universidad de Málaga
• Miguel Hernández University of Elche
• Universidad de Murcia
• Universidad de Navarra
• Universidad de Oviedo
• Autonomous University of Barcelona
• Universidad Rey Juan Carlos
• Universitat Rovira i Virgili
• Universidad de Salamanca
• Universidad de Santiago de Compostela
• Universidad de Sevilla
• Universidad de Valladolid
• Universitat de València
• Universidad de Zaragoza

Worldwide:

• Stanford University
• Kingston University
• London City University
• Newman University
• University of London
• University of Oxford
• University of Alabama

Market Growth of Vaccine Research in the last and upcoming ten years

The global vaccine market is one of the fastest growing segments and new predictions estimate the value of the market to reach between $48 billion and more than $70 billion over the next five to eight years.

According to a new report released by Transparency Market Research, the value of the global human vaccines market is expected to grow from a $28.3 billion in 2015 to $72.5 billion in 2024. The projection would represent a compound annual growth rate (CAGR) of 11.2% from 2016 to 2024. Even though the dollar figure is large and growing, vaccines still only account 3% of the market share within the global pharmaceutical industry. The report broke down expectations by segments. By age group, paediatric vaccines accounted for 57.5% of the share in 2015, but adult vaccines are expected to grow at a 13.2% CAGR during the forecast period. When the research group analysed the market by product, they found the pneumococcal segment to have the majority share in 2015, but expect hepatitis products to demonstrate strong growth through 2024. By vaccine type, the conjugate vaccines held the majority share in 2015, but the combination vaccines were expected to have the largest CAGR.